We narrowed to 148 results for: GFP expression plasmids
- 
  Viral Prep#198513-AAV1PurposeReady-to-use AAV1 particles produced from pAAV_hSyn-PdCO-EGFP-WPRE (#198513). In addition to the viral particles, you will also receive purified pAAV_hSyn-PdCO-EGFP-WPRE plasmid DNA. Synapsin-driven expression of the optimized opsin PdCO in frame with EGFP. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsEGFPAvailable SinceApril 10, 2024AvailabilityAcademic Institutions and Nonprofits only
 - 
  
pAAV_hSyn-PdCO-EGFP-WPRE (AAV5)
Viral Prep#198513-AAV5PurposeReady-to-use AAV5 particles produced from pAAV_hSyn-PdCO-EGFP-WPRE (#198513). In addition to the viral particles, you will also receive purified pAAV_hSyn-PdCO-EGFP-WPRE plasmid DNA. Synapsin-driven expression of the optimized opsin PdCO in frame with EGFP. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsEGFPAvailable SinceApril 10, 2024AvailabilityAcademic Institutions and Nonprofits only - 
  
pAAV-CAG-GFP (AAV CAP-B22)
Viral Prep#37825-CAP-B22PurposeReady-to-use AAV CAP-B22 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV were produced with the CAP-B22 serotype, which permits efficient transduction of neurons and astrocytes in the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCAGTagsGFPAvailable SinceNov. 8, 2023AvailabilityAcademic Institutions and Nonprofits only - 
  
pAAV-CAG-GFP (AAV CAP-B10)
Viral Prep#37825-CAP-B10PurposeReady-to-use AAV CAP-B10 particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. CAG-driven GFP expression. These AAV were produced with the CAP-B10 serotype, which permits efficient transduction of both inhibitory and excitatory neurons in the central nervous system. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCAGTagsGFPAvailable SinceNov. 8, 2023AvailabilityAcademic Institutions and Nonprofits only - 
  
pAAV-EF1α1.1-GFP (AAV2)
Viral Prep#122100-AAV2PurposeReady-to-use AAV2 particles produced from pAAV-EF1α1.1-GFP (#122100). In addition to the viral particles, you will also receive purified pAAV-EF1α1.1-GFP plasmid DNA. EF1a-driven expression of GFP. These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1a(1.1kb short version)TagsGFPAvailable SinceAug. 7, 2025AvailabilityAcademic Institutions and Nonprofits only - 
  
pAAV-CAG-GFP (AAV Retrograde trial size)
Viral Prep#37825-AAVrg.TPurposeReady-to-use AAV Retrograde trial size particles produced from pAAV-CAG-GFP (#37825). In addition to the viral particles, you will also receive purified pAAV-CAG-GFP plasmid DNA. GFP expression control. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.DepositorPromoterCAGTagsGFPAvailable SinceJuly 12, 2019AvailabilityAcademic Institutions and Nonprofits only - 
  
pAAV-hSyn-EGFP (AAV Retrograde trial size)
Viral Prep#50465-AAVrg.TPurposeReady-to-use AAV Retrograde trial size particles produced from pAAV-hSyn-EGFP (#50465). In addition to the viral particles, you will also receive purified pAAV-hSyn-EGFP plasmid DNA. hSyn-driven EGFP expression. These AAV preparations are suitable purity for injection into animals. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons.DepositorPromoterSynTagsEGFPAvailable SinceJuly 12, 2019AvailabilityAcademic Institutions and Nonprofits only - 
  
pAAV.CAGFLEX.(cyto).cpSFGFP.HaloTag (AAV5)
Viral Prep#209658-AAV5PurposeReady-to-use AAV5 particles produced from pAAV.CAGFLEX.(cyto).cpSFGFP.HaloTag (#209658). In addition to the viral particles, you will also receive purified pAAV.CAGFLEX.(cyto).cpSFGFP.HaloTag plasmid DNA. CAG-driven, Cre-dependent expression of cpSFGFP.HaloTag (non-responsive control). These AAV preparations are suitable purity for injection into animals.DepositorPromoterCAGTagsSFGFPAvailable SinceOct. 29, 2025AvailabilityAcademic Institutions and Nonprofits only - 
  
pAAV-hSyn-DIO-EGFP (AAV Retrograde)
Viral Prep#50457-AAVrgPurposeReady-to-use AAV Retrograde particles produced from pAAV-hSyn-DIO-EGFP (#50457). In addition to the viral particles, you will also receive purified pAAV-hSyn-DIO-EGFP plasmid DNA. hSyn-driven, Cre-dependent EGFP expression. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.DepositorPromoterSynTagsEGFP (Cre-dependent)Available SinceNov. 8, 2017AvailabilityAcademic Institutions and Nonprofits only - 
  
pAAV-FLEX-EGFPL10a (AAV5)
Viral Prep#98747-AAV5PurposeReady-to-use AAV5 particles produced from pAAV-FLEX-EGFPL10a (#98747). In addition to the viral particles, you will also receive purified pAAV-FLEX-EGFPL10a plasmid DNA. Cre-dependent EGFPL10a (EGFP-tagged ribosomal protein) expression for translating ribosome affinity purification (TRAP). These AAV preparations are suitable purity for injection into animals.DepositorPromoterEF1aTagsEGFP (Cre-dependent)Available SinceSept. 28, 2018AvailabilityAcademic Institutions and Nonprofits only